皮下植入式心律转复除颤器：优势及改进机遇
S-ICDs: advantages and opportunities for improvement.
作者信息
Friedli Axel, Burri Haran
机构信息
Department of Cardiology, University Hospital of Geneva, Geneva, Switzerland.
出版信息
Expert Rev Med Devices. 2022 Mar;19(3):237-245. doi: 10.1080/17434440.2022.2054335. Epub 2022 Mar 17.
INTRODUCTION
The subcutaneous implantable cardioverter defibrillator (S-ICD) is currently in its third generation and has been adopted in guidelines and in mainstream clinical practice. Considerable improvements have been made since the introduction of this device over a decade ago.
AREAS COVERED
A literature search was undertaken in Pubmed on articles relating to the S-ICD.
EXPERT OPINION
The therapy has been proven to be safe and effective and is a valuable option in selected patients. Nevertheless, there remain many shortcomings of the S-ICD which are discussed in this review, and which hopefully will be addressed by future generations of the device.
引言
皮下植入式心律转复除颤器（S-ICD）目前已发展到第三代，并已被纳入指南及主流临床实践。自十多年前该设备问世以来，已取得了相当大的改进。
涵盖领域
在PubMed上对与S-ICD相关的文章进行了文献检索。
专家观点
该疗法已被证明是安全有效的，对于特定患者是一种有价值的选择。然而，S-ICD仍存在许多缺点，本文对此进行了讨论，希望未来几代设备能够解决这些问题。
Zotero 插件